How Mounjaro and Wegovy Starter Doses Compare
Understanding Mounjaro and Wegovy Starter Dose Requirements
When beginning treatment with either Mounjaro or Wegovy, understanding the starter dose protocol is essential for safe and effective weight management. Wegovy's starter dose is 0.25mg taken once weekly for the first four weeks, designed to help your body gradually adjust to semaglutide while minimising potential side effects like nausea or digestive discomfort. Mounjaro follows a similar cautious approach with its own starter dose of 2.5mg weekly for four weeks, allowing patients to adapt to tirzepatide's dual-action mechanism. Both treatments require this gradual introduction because jumping to higher doses immediately can increase the likelihood of gastrointestinal side effects.
The starter dose phase serves as your body's introduction to these powerful weight management medications, each working through different but complementary pathways. Wegovy's semaglutide targets GLP-1 receptors specifically, while Mounjaro's tirzepatide activates both GIP and GLP-1 receptors for its dual-action approach. During these initial weeks, patients typically notice appetite changes and improved feelings of fullness after meals, though significant weight changes usually become more apparent during the dose escalation phases. Your prescriber will monitor your response during the starter dose period to ensure you're tolerating the treatment well before progressing to higher doses. Neither starter dose can be skipped or accelerated, as this careful titration schedule is crucial for both safety and long-term treatment success.
Mounjaro and Wegovy Pricing for Starter Doses
EverydayMeds offers transparent pricing for both Mounjaro and Wegovy starter doses, making it easy to begin your weight management journey affordably. Wegovy's 0.25mg starter dose costs £79.99, with new customers applying discount code FIRST40 at checkout to reach this final price. Our Intro Duo bundle combines the first two doses (0.25mg and 0.5mg) for £169.99, providing eight weeks of treatment with the convenience of fewer orders and Reliable Supply continuity. For patients who prefer taking the starter dose slowly, our Gentle Start Trio includes two 0.25mg pens plus one 0.5mg pen for £269.99, allowing extended time at the lowest dose if needed.
Returning customers can use code DOSE25 at checkout for ongoing savings throughout their treatment journey. All prices include our comprehensive service: clinical assessment, prescriber review, and next-day cold-chain delivery once approved. The 16-week dose escalation schedule progresses from 0.25mg to 0.5mg, then 1mg, 1.7mg, and finally the maintenance dose of 2.4mg, with each pen lasting exactly four weeks. We offer similar pricing transparency for Mounjaro, allowing you to compare costs across your entire treatment timeline before making your decision.
Clinical Evidence Behind Mounjaro and Wegovy Effectiveness
Both Mounjaro and Wegovy have demonstrated significant efficacy in clinical trials, though their different mechanisms and trial designs make direct comparisons inappropriate. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme also showed sustained results, with STEP 5 demonstrating 15.2% average weight loss maintained at two years with continued treatment.
Mounjaro's clinical evidence comes from the SURMOUNT trials, which evaluated tirzepatide's dual GIP and GLP-1 receptor agonism in weight management. These trials used different methodologies and patient populations compared to the STEP programme, making percentage-based comparisons between the two treatments scientifically invalid. Both medications are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity for optimal results. Your prescriber will consider your individual medical history, current medications, and treatment goals when determining which option may be more suitable for your circumstances.
How Wegovy Works During the Starter Dose Phase
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a naturally occurring hormone called glucagon-like peptide-1. When you inject the starter dose of 0.25mg weekly, semaglutide binds to GLP-1 receptors in your brain's appetite control centres, specifically in the hypothalamus and brain stem areas that regulate hunger and satiety. This mechanism helps reduce appetite between meals and promotes earlier feelings of fullness when eating, naturally supporting smaller portion sizes without the sensation of deprivation. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satisfaction after meals. During the starter dose weeks, these effects begin gently, allowing your digestive system to adjust gradually while you begin noticing changes in your relationship with food and hunger patterns. The 0.25mg dose provides therapeutic benefit while minimising the gastrointestinal side effects that can occur when GLP-1 receptor agonists are introduced too quickly.
Ordering Process for Mounjaro and Wegovy Starter Doses
Beginning treatment with either Mounjaro or Wegovy through EverydayMeds involves a streamlined three-step process designed for convenience and clinical safety. First, complete our comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any contraindications that might affect treatment suitability. Next, our qualified prescribers review your assessment within three working days (or 24 hours with our express service), ensuring either Mounjaro or Wegovy is appropriate for your individual circumstances. Once approved, your starter dose ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. All treatments are dispensed from our GPhC-registered pharmacy (#9012878), ensuring full compliance with UK pharmaceutical regulations. You'll receive detailed injection instructions, storage guidelines, and access to our ongoing clinical support throughout your treatment journey.
Storage Differences Between Mounjaro and Wegovy Starter Doses
Understanding proper storage requirements is crucial for maintaining the effectiveness of both Mounjaro and Wegovy throughout your treatment. Both medications must be stored in the refrigerator at 2-8°C before first use, but they differ significantly in their room temperature stability once removed from refrigeration. Wegovy offers superior travel flexibility, remaining stable for up to six weeks at room temperature below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both use pre-filled injection pens—Wegovy's FlexTouch pen and Mounjaro's own pre-filled system—designed for easy weekly self-administration. The dose escalation schedule requires careful planning: you cannot skip doses or accelerate the titration timeline for safety reasons, so maintaining proper storage and having your next dose ready is essential. Never freeze either medication, and protect from direct sunlight during storage, whether refrigerated or at room temperature during the permitted periods.
Choosing Between Mounjaro and Wegovy for First-Time Users
First-time users comparing Mounjaro and Wegovy should understand that both represent different approaches to weight management medication, each with unique advantages depending on individual circumstances. Wegovy's single-action GLP-1 mechanism has extensive long-term data and the convenience of longer room temperature stability for travel or lifestyle flexibility. Mounjaro's dual GIP and GLP-1 receptor action offers a newer approach that some patients may find suits their response patterns better, though it requires more careful temperature management.
The choice between these treatments isn't about one being superior to the other, but rather which mechanism and practical considerations align better with your lifestyle, medical history, and treatment preferences. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option is right for your specific situation. Factors like travel frequency, injection preferences, previous treatment responses, and individual tolerance patterns all contribute to the decision-making process during your clinical assessment.
Start Your Mounjaro and Wegovy Journey Today
Ready to begin your weight management journey with either Mounjaro or Wegovy? EverydayMeds makes starting simple with transparent pricing, expert clinical support, and next-day delivery to your door. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 for ongoing savings throughout their treatment. Our comprehensive service includes everything you need: clinical assessment, prescriber review, detailed injection guidance, and continued support as you progress through the dose escalation schedule. Visit our Wegovy starter dose page at https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your assessment today. Both treatments require commitment to dietary changes and increased physical activity, but with proper support and the right medication choice, sustainable weight management is achievable. Don't wait—take the first step towards your health goals with confidence, knowing you're supported by our experienced clinical team every step of the way.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
